Dec 22, 2022 · Subunit, recombinant, polysaccharide, and conjugate vaccines use specific pieces of the germ—like its protein, sugar, or capsid (a casing around the germ). Because these …

A recombinant protein vaccine does not carry that risk and may even be an ideal complement to elicit a more desired and prolonged immune response in a prime-boost approach. Data from …

Mar 1, 2021 · Most current COVID-19 recombinant protein vaccine candidates are expressed in mammalian cell culture-based expression systems (Table 1) that have been used to produce …

There are two vaccines in use against HPV, which have both been developed based on VLPs derived from HPV-6, -11, -16, and/or -18 subtypes. These vaccines utilize the L1 recombinant …

Here, we summarize the current public information on the nature and on the development status of recombinant subunit antigens and adjuvants targeting SARS-CoV-2 infections. Keywords: …

Protein-based subunit vaccines use specific isolated proteins as antigens and in addition to purification from natural sources, they can be produced as heterologous proteins in …

Apr 23, 2021 · Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, …

Mar 1, 2021 · Here, we summarize the current public information on the nature and on the development status of recombinant subunit antigens and adjuvants targeting SARS-CoV-2 …

Apr 19, 2021 · Paul Goepfert and colleagues 1 describe clinical studies of CoV2 preS dTM, a stabilised pre-fusion spike protein vaccine produced in a baculovirus expression system …

Apr 19, 2021 · CoV2 preS dTM is a stabilised pre-fusion spike protein vaccine produced in a baculovirus expression system being developed against SARS-CoV-2. We present interim …